Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Liraglutide, a GLP-1 receptor agonist already approved for diabetes and obesity, may also reduce depressive symptoms in patients with major depressive disorder (MDD), according to a Phase II clinical trial ... Read More
Continuous Coverage
A peer-reviewed study published this week in the journal Nature Communications reports that four days of extreme, unseasonal…
A recent analysis of the project known as Disclosure Day suggests that the production, which was once associated…
Fresh Plum, Walnut and Wisconsin Gorgonzola Pizza is now available at Ted’s IGA Supermarkets across Wisconsin, offering customers…
Ousmane Dembélé’s surprise appearance in Boston with the French national team has sent shockwaves through global football—sparking speculation…
As of June 2026, the LiGiTa (Liechtensteiner Gitarrentage) festival is preparing to host virtuoso guitarist Yamandu Costa, with…
RESI-CORP, a mid-market Ecuadorian real estate and construction firm, is expanding its marketing and sales operations in Quito…
Global Affairs
The inquest into the death of 14-year-old Noah Donohoe in Belfast, Northern Ireland, continues as friends testified they…
Markets And Money
U.S. consumer prices rose 4.2% year-over-year in May 2026—the highest since March 2023—driven by a 12.8% surge in…
Digital Culture
IEEE’s 2026 EPICS Contributor Awards recognize three engineers—Surattana Kakay (Thailand), Navid Shaghaghi (USA), and Elizabeth Vidal-Duarte (Peru)—whose projects…
Science And Wellbeing
The New York Knicks staged a historic 33-point comeback from a 29-point deficit in Game 4 of the…
Screen And Sound
NBA star Victor Wembanyama and teammate Harrison Barnes are quietly running a book club that fans want to…
Fixtures And Form
KSI, the YouTuber and rapper, has released a documentary detailing his ownership of Dagenham & Redbridge FC, marking…
